Effect of HPMC on solubility and dissolution of carbamazepine form III in simulated gastrointestinal fluids

Main Article Content

S B Bhise
M Rajkumar


The effect of HPMC on solubility and dissolution of carbamazepine form III (CBZ) was investigated in 50% w/w of CBZ form III in HPMC solid dispersion and physical mixture. Powdered samples of CBZ form III, physical mixture, and solid
dispersion were characterized for thermal behavior (DSC), crystallinity (PXRD), and compatibility (FT-IR). Solubility and dissolution studies were carried out in different simulated gastrointestinal fluids and de-ionized water. Solubility studies in simulated gastric fluid (SGF) revealed that acidic pH favors formation of CBZ dihydrate.Triton X 100 in blank fast-state simulated gastric fluid (FaSSGF) prevents the formation of CBZ dihydrate in acidic pH. A maximum solubility of 268.77 μg/mL was achieved with fed-state simulated intestinal fluid (FeSSIF). Correlation between solubility and pH could not be established. Both solubility and dissolution studies revealed that HPMC had a profound effect of enhancement of solubility and dissolution of CBZ form III in both physical mixtures and solid dispersions. HPMC prevents the formation of CBZ dihydrate and thereby
improves the solubility and dissolution. This was further correlated with results obtained from DSC and XRD. There was no drastic difference in solubility and dissolution of CBZ form III with different media. It was observed that there was no existing relationship between solubility and dissolution of CBZ form III in different media.


Download data is not yet available.

Article Details

How to Cite
Bhise, S. B., & Rajkumar, M. (2014). Effect of HPMC on solubility and dissolution of carbamazepine form III in simulated gastrointestinal fluids. Asian Journal of Pharmaceutics (AJP), 2(1). https://doi.org/10.22377/ajp.v2i1.170


Amidon G, Lennernas H, Shah VP. A theortical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413-20.

Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin

Pharmacokinet 1978;3:128-43.

Marazban S, Judith B, Xiaoxia C. Enhanced drug dissolution using

evaporative precipitation into aqueous solution. Int J Pharm


Yumiko K, Shusei I, Shigeru I. Physicochemical properties and

bioavailability of carbamazepine polymorphs and dehydrate. Int J Pharm


Haiyan MQ, Kallas LJ. Solubility and stability of anhydrate/hydrate in

solvent mixtures. Int J Pharm 2006;321:101-7.

Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30

by conventional solvent evaporation and supercritical methods. Int

J Pharm 2004;272:1-10.

Katzhendler I, Azoury R, Friedman M. Crystalline properties of

carbamazepine in sustained release hydrophilic matrix tablets based

on hydroxypropyl methyl cellulose. J Control Release 1998;54:69-

Mitchell SA, Reynolds TD, Dasbach TP. A compaction process to enhance

dissolution of poorly water soluble drugs using hydroxypropyl methyl

cellulose. Int J Pharm 2003;250:3-11.

Fang T, Niklas S, Jaakko A. Influence of polymorphic form, morphology,

and excipients interactions on the dissolution of carbamazepine

compacts. J Pharma Sci 2006;10:1002- 13.

Thorsteinn L, Hafrun F. The effect of water-soluble polymers on the

aqueous solubility and complexing abilities of beta cyclodextrin. Int

J Pharma 1998;163:115-21.

Behme RJ, Brooke D. Heat of fusion measurement of a low melting

polymorph of carbamazepine that undergoes multiple-phase

changes during differential scanning calorimetry analysis. J Pharm Sci


Dressman J, Johannes K. Pharmaceutical dissolution testing, Taylor and

Francis, Boca Raton; 1, 2005. p. 206.

Agarwal S, Ashokraj Y, Bharatam PV. Solid-state characterization of

rifampicin samples and its biopharmaceutic relevance. Eur J Pharm Sci


Jez-Willian BB, Ronei JP. Figures of merit for the determination of the

polymorphic purity of carbamazepine by infrared spectroscopy and

multivariate calibration. J Pharm Sci 2004;93:2124-35.

Kalantzi L, Furat T, Abrahamsson B, Characterization of the human upper gastrointestinal contents under conditions simulation bioavailability

studies in the fasting and fed states. Salt Lake City, UT: AAPS Annual

Meeting; 2003.

James EP, Michael BJ, Angus HF. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds. J Pharm Sci 2005;94:1998-2013.

Otsuka M, Ohfusa T, Matsuda Y. Effect of binders on polymorphic

transformation kinetics of carbamazepine in aqueous solution. Colloids

Surfaces B Biointerf 2000;17:145-52.